This comparison did not detect any reductions in the constitutive pretreatment levels of either MCPyV large T-antigen mRNA expression, Δ exon 6–7 TrkAIII mRNA expression or TrkA and phosphorylated TrkA isoform(s) IF immunoreactivity in tumours that relapsed following treatment. Here, NTRK1 is linked to neoplasm.